600594.SHG Guizhou Yibai Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
3.26 CNY
Close of Nov 5, 2026
2.85 5.27
Market cap
CNY 2.58B
P/E
-
P/B
1.23x
ROE
-9.9%
Dividend yield
1.11%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600594.SHG undervalued?

Graham number

The Graham number of Guizhou Yibai Pharmaceutical Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Guizhou Yibai Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Guizhou Yibai Pharmaceutical Co Ltd yet.

Guizhou Yibai Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Guizhou Yibai Pharmaceutical Co Ltd

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells novel pharmaceutical products in China. The company offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, lyophilized powder injections, dripping pills, and oral solutions in the areas of tumor system, cerebrovascular and cardiovascular, respiratory system, rheumatic bone, digestive system, pediatric, anti-infection, anti-inf…

Full company profile